Page last updated: 2024-11-02

phenylbutazone and Connective Tissue Diseases

phenylbutazone has been researched along with Connective Tissue Diseases in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Connective Tissue Diseases: A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BANNERJEE, SK1
TAYLOR, P1

Other Studies

1 other study available for phenylbutazone and Connective Tissue Diseases

ArticleYear
Hydroxyphenylbutazone in the treatment of nodular scleritis.
    Transactions of the ophthalmological societies of the United Kingdom, 1961, Volume: 81

    Topics: Connective Tissue Diseases; Humans; Oxyphenbutazone; Phenylbutazone; Sclera; Scleral Diseases; Scler

1961